# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001370053-23-000033
Filing Date
2023-04-27
Accepted
2023-04-27 16:05:36
Documents
8
Period of Report
2023-06-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | proxystatementfy2022_def14a.htm | DEF 14A | 553001
2 | PROXY CARD | anaptybiopcv-3_001a.jpg | GRAPHIC | 181610
3 | PROXY CARD | anaptybiopcv-3_002a.jpg | GRAPHIC | 118127
4 | COMPENSATION GRAPH | compensation_graphx1a.jpg | GRAPHIC | 113878
5 | COMPENSATION GRAPH | compensation_graphx2a.jpg | GRAPHIC | 120238
6 | DFSIGNATURE | dfsignaturea.jpg | GRAPHIC | 4102
7 | LOGO | image_0a.jpg | GRAPHIC | 13951
8 | JTSIGNATURE | jtsignature1a02a.jpg | GRAPHIC | 58580
| Complete submission text file | 0001370053-23-000033.txt |  | 1389876

Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37985 | Film No.: 23856777
SIC: 2834 Pharmaceutical Preparations